HER2/PD1 bispecific antibody in IgG4 subclass with superior anti‐tumour activities

Detalles Bibliográficos
Autores principales: Chu, Wendi, Xu, Hui, Wang, Yanfei, Xie, Yongle, Chen, Yi‐Li, Tan, Xiaorong, Huang, Chenghao, Wang, Guifeng, Wang, Qi, Luo, Wenxin, Xia, Ningshao, Geng, Meiyu, Xie, Zuoquan, Wang, Chunhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982313/
https://www.ncbi.nlm.nih.gov/pubmed/35384333
http://dx.doi.org/10.1002/ctm2.791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982313/
https://www.ncbi.nlm.nih.gov/pubmed/35384333
http://dx.doi.org/10.1002/ctm2.791

Ejemplares similares